These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 2332568)

  • 1. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
    Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
    J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
    Vella PP; Ellis RW
    Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
    Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy.
    Peltola H; Eskola J; Käyhty H; Takala AK; Mäkelä PH
    Arch Pediatr Adolesc Med; 1994 Jun; 148(6):620-5. PubMed ID: 8193690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
    J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Jelonek MT; Chang SJ; Chiu CY; Park MK; Nahm MH; Ward JI
    Infect Immun; 1993 Dec; 61(12):5345-50. PubMed ID: 8225608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of Haemophilus influenzae type B vaccines in children with hepatoportoenterostomies.
    Rosenthal P; Wong V; Ross LA; Kim KS
    J Pediatr Gastroenterol Nutr; 1990 Aug; 11(2):201-4. PubMed ID: 2395059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
    Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
    Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
    Barbour ML; Booy R; Crook DW; Griffiths H; Chapel HM; Moxon ER; Mayon-White D
    Pediatr Infect Dis J; 1993 Jun; 12(6):478-84. PubMed ID: 8345980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
    Marchant CD; Band E; Froeschle JE; McVerry PH
    Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
    Heath PT
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines.
    Siber GR; Anderson R; Habafy M; Gupta RK
    Vaccine; 1995 Apr; 13(6):525-31. PubMed ID: 7483772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Lieberman JM; Greenberg DP; Wong VK; Partridge S; Chang SJ; Chiu CY; Ward JI
    J Pediatr; 1995 Feb; 126(2):198-205. PubMed ID: 7844665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro induction of a Haemophilus influenzae type b polysaccharide-specific antibody response in human peripheral blood lymphocytes of individuals recently vaccinated with an oligosaccharide-protein conjugate.
    Peeters CC; Tenbergen-Meekes AM; Heijnen CJ; Poolman JT; Zegers BJ; Rijkers GT
    J Immunol; 1991 Dec; 147(12):4192-9. PubMed ID: 1753096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
    J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.
    Eskola J; Käyhty H; Peltola H; Karanko V; Mäkelä PH; Samuelson J; Gordon LK
    Lancet; 1985 May; 1(8439):1184-6. PubMed ID: 2860387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.